Biomerica, Inc.
BMRA
$0.5725
-$0.0315-5.22%
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 7.83% | 0.61% | 16.27% | 10.67% | -9.35% |
| Total Depreciation and Amortization | 10.23% | 9.22% | 6.55% | -36.95% | -39.55% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 38.17% | -3.79% | -54.03% | 250.49% | -29.19% |
| Change in Net Operating Assets | -2,480.00% | 115.17% | -897.37% | 89.71% | 95.79% |
| Cash from Operations | 4.30% | 9.76% | 2.06% | 39.77% | -11.11% |
| Capital Expenditure | 27.27% | 41.18% | 20.31% | 69.49% | 65.91% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 20.97% | 60.71% | -357.14% | -19,600.00% | -1,412.20% |
| Cash from Investing | 23.16% | 51.40% | -47.44% | -19.32% | 5.85% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -95.12% | -- | -- | 275.49% | 190.84% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 85.76% | 87.69% | 88.51% | -1,120.97% | -834.19% |
| Cash from Financing | -95.95% | -101.06% | -100.86% | 253.76% | 174.12% |
| Foreign Exchange rate Adjustments | 11.11% | 76.47% | 122.22% | 117.96% | 75.41% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -330.38% | -370.15% | -245.95% | 128.91% | 197.00% |
